Todd Holmes
Todd is the Founder and Managing Partner of NewVale Capital LLC. He has more than 20 years of life science investing, company-building, and transaction experience
Todd is the Founder and Managing Partner of NewVale Capital LLC. He has more than 20 years of life science investing, company-building, and transaction experience
Scott has led and advised life sciences companies for more than 25 years with a focus on CDMOs since 2010. Scott consults for the pharma
With 34 years of life sciences experience in senior management, R&D, operations, and quality, Rick was most recently the CEO of Althea Technologies Inc. Prior
Before joining Telegraph Hill Partners, Paul Grossman was Head of Strategy and Corporate Development for Life Technologies, holding a similar position at Invitrogen Corporation prior
Before joining Telegraph Hill Partners, Alex worked at Genzyme Corporation in the Oncology / Multiple Sclerosis Business Development Group, where he sourced, evaluated, and executed
With over 30 years of experience in lyophilization technologies, microchannel diagnostic cartridge design, and the founder of Lyogen LLC, Mark Nowakowski has joined the Argonaut